Literature DB >> 26935463

Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials of Orthopaedic Surgical Interventions.

Jan J Rongen1, Gerjon Hannink2.   

Abstract

BACKGROUND: The selective reporting of a subset of the outcomes that had been originally reported to a registry is a potential threat to the validity of evidence-based medicine. The extent of selective reporting has not been described for randomized controlled trials (RCTs) assessing the effectiveness of orthopaedic surgical interventions. The objective of this study was (1) to determine the percentage of orthopaedic surgical RCTs published in high-impact orthopaedic journals that were reported to have been registered, (2) to evaluate the consistency between the primary outcome measures recorded in the registry and those reported in the article, and (3) to evaluate whether selective reporting favored statistically significant outcomes.
METHODS: We searched PubMed for articles on RCTs assessing orthopaedic surgical interventions indexed from January 2010 through December 2014 and published in the ten orthopaedic journals with the highest impact factors. For every article in which the authors reported registration of the RCT, we extracted the number and nature of the outcome measures from the article and the corresponding information from the registry. We then evaluated the consistency between the primary outcome measures reported in the registry and those reported in the published article. Moreover, we evaluated whether selective reporting favored statistically significant outcomes.
RESULTS: Of the 362 articles on orthopaedic surgical RCTs, ninety (24.9%) reported that the RCT had been registered and thirty-four (37.8%) of the ninety had been registered adequately (registered before the study end with a clear description of the primary outcome measure and its time frame, with no substantial change after the study end). Twenty-six reports were eligible for our evaluation of the consistency between the registered primary outcome measures and those reported in the published article. This analysis identified one or multiple major discrepancies for fourteen articles, eight of which favored statistically significant results.
CONCLUSIONS: Few articles on orthopaedic surgical RCTs reported registration of the trial, and even fewer of these trials were registered adequately. Inconsistencies between registered primary outcome measures and those reported in the published articles, as well as selective outcome reporting favoring statistically significant outcomes, were prevalent. CLINICAL RELEVANCE: Although trial registration is now the rule, it is currently far from optimal for orthopaedic surgical RCTs, and selective outcome reporting is prevalent. Full involvement of authors, editors, and reviewers is necessary to ensure publication of quality, unbiased results.
Copyright © 2016 by The Journal of Bone and Joint Surgery, Incorporated.

Mesh:

Year:  2016        PMID: 26935463     DOI: 10.2106/JBJS.15.00400

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  12 in total

1.  [Distal radius fractures - Evidence is Shlevidence].

Authors:  D Stengel; C Bartl
Journal:  Unfallchirurg       Date:  2016-09       Impact factor: 1.000

2.  Full publication of results initially presented in abstracts.

Authors:  Roberta W Scherer; Joerg J Meerpohl; Nadine Pfeifer; Christine Schmucker; Guido Schwarzer; Erik von Elm
Journal:  Cochrane Database Syst Rev       Date:  2018-11-20

Review 3.  Shoulder Arthroplasty Trials Are Infrequently Registered: A Systematic Review of Trials.

Authors:  Matthew Thomas Sims; Zachary Carter Sanchez; James Murphy Herrington; James Barrett Hensel; Nolan Michael Henning; Caleb Josiah Scheckel; Matt Vassar
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

4.  A systematic review of comparisons between protocols or registrations and full reports in primary biomedical research.

Authors:  Guowei Li; Luciana P F Abbade; Ikunna Nwosu; Yanling Jin; Alvin Leenus; Muhammad Maaz; Mei Wang; Meha Bhatt; Laura Zielinski; Nitika Sanger; Bianca Bantoto; Candice Luo; Ieta Shams; Hamnah Shahid; Yaping Chang; Guangwen Sun; Lawrence Mbuagbaw; Zainab Samaan; Mitchell A H Levine; Jonathan D Adachi; Lehana Thabane
Journal:  BMC Med Res Methodol       Date:  2018-01-11       Impact factor: 4.615

Review 5.  A systematic review of the processes used to link clinical trial registrations to their published results.

Authors:  Rabia Bashir; Florence T Bourgeois; Adam G Dunn
Journal:  Syst Rev       Date:  2017-07-03

6.  Inconsistent selection of outcomes and measurement devices found in shoulder arthroplasty research: An analysis of studies on ClinicalTrials.gov.

Authors:  Matthew Thomas Sims; Byron Nice Detweiler; Jared Thomas Scott; Benjamin McKinnley Howard; Grant Richard Detten; Matt Vassar
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

7.  Registration and Outcome-Reporting Bias in Randomized Controlled Trials of Distal Radial Fracture Treatment.

Authors:  Shiela Lee; Tanvir Khan; Douglas Grindlay; Alexia Karantana
Journal:  JB JS Open Access       Date:  2018-07-24

8.  Characteristics of Randomized Clinical Trials in Surgery From 2008 to 2020: A Systematic Review.

Authors:  N Bryce Robinson; Stephen Fremes; Irbaz Hameed; Mohamed Rahouma; Viola Weidenmann; Michelle Demetres; Mahmoud Morsi; Giovanni Soletti; Antonino Di Franco; Marco A Zenati; Shahzad G Raja; David Moher; Faisal Bakaeen; Joanna Chikwe; Deepak L Bhatt; Paul Kurlansky; Leonard N Girardi; Mario Gaudino
Journal:  JAMA Netw Open       Date:  2021-06-01

9.  The reporting of outcomes in randomised controlled trials: The switch and the spin.

Authors:  M Ghert
Journal:  Bone Joint Res       Date:  2017-10       Impact factor: 5.853

Review 10.  Evidence of selective reporting bias in hematology journals: A systematic review.

Authors:  Cole Wayant; Caleb Scheckel; Chandler Hicks; Timothy Nissen; Linda Leduc; Mousumi Som; Matt Vassar
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.